Download PDF
Semin Respir Crit Care Med 2019; 40(02): 159-172
DOI: 10.1055/s-0039-1685165
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Computed Tomographic Imaging in Connective Tissue Diseases

Joseph Barnett
1   Department of Radiology, Royal Brompton Hospital, London, United Kingdom
,
Anand Devaraj
1   Department of Radiology, Royal Brompton Hospital, London, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
28 May 2019 (online)

    Permissions and Reprints

Abstract

Pulmonary disease represents a significant extra-articular manifestation in the majority of connective tissue diseases (CTDs). The identification, classification, and staging of pulmonary involvement are centrally important to the management of patients, aiding the prognostication of disease behavior and treatment decisions. We present a review of the high-resolution computed tomographic pulmonary features of CTD in the lung and their significance to the reporting radiologist.

Keywords

HRCT - connective tissue disease - fibrosis
 

  • References

  • 1 Mikuls TR, Payne JB, Deane KD, Thiele GM. Autoimmunity of the lung and oral mucosa in a multisystem inflammatory disease: the spark that lights the fire in rheumatoid arthritis?. J Allergy Clin Immunol 2016; 137 (01) 28-34
    CrossrefPubMedSearch in Google Scholar
  • 2 Sokka T, Kautiainen H, Toloza S. , et al; QUEST-RA Group. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007; 66 (11) 1491-1496
    CrossrefPubMedSearch in Google Scholar
  • 3 Hyldgaard C. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival. Dan Med J 2015; 62 (04) B5069
    PubMedSearch in Google Scholar
  • 4 Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology 1994; 193 (02) 375-382
    CrossrefPubMedSearch in Google Scholar
  • 5 Tanaka N, Kim JS, Newell JD. , et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004; 232 (01) 81-91
    CrossrefPubMedSearch in Google Scholar
  • 6 Allain J, Saraux A, Guedes C, Valls I, Devauchelle V, Le Goff P. Prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis. Rev Rhum Engl Ed 1997; 64 (10) 531-537
    PubMedSearch in Google Scholar
  • 7 Aronoff A, Bywaters EG, Fearnley GR. Lung lesions in rheumatoid arthritis. BMJ 1955; 2 (4933): 228-232
    CrossrefPubMedSearch in Google Scholar
  • 8 Walker WC, Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine (Baltimore) 1968; 47 (06) 501-520
    PubMedSearch in Google Scholar
  • 9 Brazeau-Lamontagne L, Charlin B, Levesque R-Y, Lussier A. Cricoarytenoiditis: CT assessment in rheumatoid arthritis. Radiology 1986; 158 (02) 463-466
    CrossrefPubMedSearch in Google Scholar
  • 10 Berjawi G, Uthman I, Mahfoud L. , et al. Cricothyroid joint abnormalities in patients with rheumatoid arthritis. J Voice 2010; 24 (06) 732-737
    CrossrefPubMedSearch in Google Scholar
  • 11 Hansell DM. HRCT of obliterative bronchiolitis and other small airways diseases. Semin Roentgenol 2001; 36 (01) 51-65
    CrossrefPubMedSearch in Google Scholar
  • 12 Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998; 157 (5 Pt 1): 1658-1665
    CrossrefPubMedSearch in Google Scholar
  • 13 Hansell DM, Rubens MB, Padley SP, Wells AU. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology 1997; 203 (03) 721-726
    CrossrefPubMedSearch in Google Scholar
  • 14 Bruguera-Àvila N, Sánchez-Martínez E, Garcia-Olivé I, Pérez-Ochoa JF, Martínez-Barenys C, Ruiz-Manzano J. Obliterating bronchiolitis in a patient treated with d-penicillamine [in Spanish]. Arch Bronconeumol 2013; 49 (09) 411-412
    PubMedSearch in Google Scholar
  • 15 Wilsher M, Voight L, Milne D. , et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med 2012; 106 (10) 1441-1446
    CrossrefPubMedSearch in Google Scholar
  • 16 Tokura S, Okuma T, Akira M, Arai T, Inoue Y, Kitaichi M. Utility of expiratory thin-section CT for fibrotic interstitial pneumonia. Acta Radiol 2014; 55 (09) 1050-1055
    CrossrefPubMedSearch in Google Scholar
  • 17 Park WH, Kim SS, Shim SC. , et al. Visual assessment of chest computed tomography findings in anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis: is it associated with airway abnormalities?. Hai 2016; 194 (01) 97-105
    PubMedSearch in Google Scholar
  • 18 Howling SJ, Hansell DM, Wells AU, Nicholson AG, Flint JDA, Müller NL. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999; 212 (03) 637-642
    CrossrefPubMedSearch in Google Scholar
  • 19 Zhang Y, Li H, Wu N, Dong X, Zheng Y. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 2017; 36 (04) 817-823
    CrossrefPubMedSearch in Google Scholar
  • 20 Kelly CA, Saravanan V, Nisar M. , et al; British Rheumatoid Interstitial Lung (BRILL) Network. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. Rheumatology (Oxford) 2014; 53 (09) 1676-1682
    CrossrefPubMedSearch in Google Scholar
  • 21 Nurmi HM, Kettunen H-P, Suoranta S-K. , et al. Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease. Respir Med 2018; 134: 24-30
    CrossrefPubMedSearch in Google Scholar
  • 22 Raghu G, Remy-Jardin M, Myers JL. , et al; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198 (05) e44-e68
    CrossrefPubMedSearch in Google Scholar
  • 23 Jacob J, Hirani N, van Moorsel CHM. , et al. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J 2019; 53 (01) 1800869
    CrossrefPubMedSearch in Google Scholar
  • 24 Solomon JJ, Ryu JH, Tazelaar HD. , et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med 2013; 107 (08) 1247-1252
    CrossrefPubMedSearch in Google Scholar
  • 25 Tanaka N, Kunihiro Y, Kubo M. , et al. HRCT findings of collagen vascular disease-related interstitial pneumonia (CVD-IP): a comparative study among individual underlying diseases. Clin Radiol 2018; 73 (09) 833.e1-833.e10
    CrossrefPubMedSearch in Google Scholar
  • 26 Tsuchiya Y, Takayanagi N, Sugiura H. , et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011; 37 (06) 1411-1417
    CrossrefPubMedSearch in Google Scholar
  • 27 Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953; 8 (01) 29-37
    CrossrefPubMedSearch in Google Scholar
  • 28 Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Rheumatoid pneumoconiosis (Caplan's syndrome). Eur J Intern Med 2010; 21 (03) 168-172
    CrossrefPubMedSearch in Google Scholar
  • 29 Mack U, Schmidt K, Heine M. [Fatal diffuse alveolar damage after gold medication]. Pneumologie 1994; 48 (05) 405-408
    PubMedSearch in Google Scholar
  • 30 Parambil JG, Myers JL, Ryu JH. Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest 2006; 130 (02) 553-558
    CrossrefPubMedSearch in Google Scholar
  • 31 Hozumi H, Nakamura Y, Johkoh T. , et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 2013; 3 (09) e003132
    CrossrefPubMedSearch in Google Scholar
  • 32 Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS. Acute exacerbations of interstitial lung diseases. Curr Opin Pulm Med 2010; 16 (05) 480-486
    CrossrefPubMedSearch in Google Scholar
  • 33 Lloyd CR, Walsh SLF, Hansell DM. High-resolution CT of complications of idiopathic fibrotic lung disease. Br J Radiol 2011; 84 (1003): 581-592
    CrossrefPubMedSearch in Google Scholar
  • 34 Cottin V, Nunes H, Mouthon L. , et al; Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63 (01) 295-304
    CrossrefPubMedSearch in Google Scholar
  • 35 Jacob J, Song JW, Yoon HY. , et al. Prevalence and effects of emphysema in never-smokers with rheumatoid arthritis interstitial lung disease. EBioMedicine 2018; 28: 303-310
    CrossrefPubMedSearch in Google Scholar
  • 36 Koslow M, Young JR, Yi ES. , et al. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. Eur Radiol 2019; 29: 1684-1692
    CrossrefPubMedSearch in Google Scholar
  • 37 Kobayashi T, Satoh K, Ohkawa M, Satoh A. Multiple rheumatoid nodules with rapid thin-walled cavity formation producing pneumothorax. J Thorac Imaging 2005; 20 (01) 47-49
    CrossrefPubMedSearch in Google Scholar
  • 38 Das CJ, Seith A, Debnath J, Kumar U, Sharma SG, Aron M. Aspergillus colonisation of pulmonary rheumatoid nodules: a rare cause of ‘bull's eye’ appearance. Indian J Chest Dis Allied Sci 2009; 51 (01) 41-43
    PubMedSearch in Google Scholar
  • 39 Young A, Koduri G, Batley M. , et al; Early Rheumatoid Arthritis Study (ERAS) group. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 2007; 46 (02) 350-357
    PubMedSearch in Google Scholar
  • 40 Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 2003; 30 (05) 958-965
    PubMedSearch in Google Scholar
  • 41 Assayag D, Elicker BM, Urbania TH. , et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 2014; 270 (02) 583-588
    CrossrefPubMedSearch in Google Scholar
  • 42 Kim EJ, Elicker BM, Maldonado F. , et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010; 35 (06) 1322-1328
    CrossrefPubMedSearch in Google Scholar
  • 43 Park I-N, Kim DS, Shim TS. , et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132 (01) 214-220
    CrossrefPubMedSearch in Google Scholar
  • 44 Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis. Chest 2016; 149 (05) 1205-1214
    CrossrefPubMedSearch in Google Scholar
  • 45 Matsumoto T, Iwano S, Takahashi N. , et al. Association between chest computed tomography findings and respiratory adverse events in rheumatoid arthritis patients undergoing long-term biological therapy. Int J Rheum Dis 2018 in press
    PubMedSearch in Google Scholar
  • 46 Lawrence RC, Helmick CG, Arnett FC. , et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41 (05) 778-799
    CrossrefPubMedSearch in Google Scholar
  • 47 Jacobsen S, Petersen J, Ullman S. , et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998; 17 (06) 468-477.
    CrossrefPubMedSearch in Google Scholar
  • 48 Kim JS, Kim D, Joo YB. , et al. Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients. Lupus 2018; 27 (11) 1769-1777
    CrossrefPubMedSearch in Google Scholar
  • 49 Kim JS, Lee KS, Koh EM, Kim SY, Chung MP, Han J. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000; 24 (01) 9-18
    CrossrefPubMedSearch in Google Scholar
  • 50 Wan SA, Teh CL, Jobli AT. Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: case series from a single institution. Lupus 2016; 25 (13) 1485-1490
    CrossrefPubMedSearch in Google Scholar
  • 51 Matthay RA, Schwarz MI, Petty TL. , et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975; 54 (05) 397-409
    PubMedSearch in Google Scholar
  • 52 Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 2000; 118 (04) 1083-1090
    CrossrefPubMedSearch in Google Scholar
  • 53 Cheah FK, Sheppard MN, Hansell DM. Computed tomography of diffuse pulmonary haemorrhage with pathological correlation. Clin Radiol 1993; 48 (02) 89-93
    CrossrefPubMedSearch in Google Scholar
  • 54 Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996; 166 (02) 301-307
    CrossrefPubMedSearch in Google Scholar
  • 55 Bankier AA, Kiener HP, Wiesmayr MN. , et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 1995; 196 (03) 835-840
    CrossrefPubMedSearch in Google Scholar
  • 56 Saito Y, Terada M, Takada T. , et al. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002; 26 (03) 349-357
    CrossrefPubMedSearch in Google Scholar
  • 57 American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165 (02) 277-304
    CrossrefPubMedSearch in Google Scholar
  • 58 Tansey D, Wells AU, Colby TV. , et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44 (06) 585-596
    CrossrefPubMedSearch in Google Scholar
  • 59 Takada H, Saito Y, Nomura A. , et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in systemic lupus erythematosus. Pediatr Pulmonol 2005; 40 (03) 257-260
    CrossrefPubMedSearch in Google Scholar
  • 60 Yood RA, Steigman DM, Gill LR. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus 1995; 4 (02) 161-163
    CrossrefPubMedSearch in Google Scholar
  • 61 Esmaeilbeigi F, Juvet S, Hwang D, Mittoo S. Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus. Can Respir J 2012; 19 (01) 50-52
    PubMedSearch in Google Scholar
  • 62 Medlin JL, Hansen KE, McCoy SS, Bartels CM. Pulmonary manifestations in late versus early systemic lupus erythematosus: a systematic review and meta-analysis. Semin Arthritis Rheum 2018; 48 (02) 198-204
    CrossrefPubMedSearch in Google Scholar
  • 63 Alamoudi OSB, Attar SM. Pulmonary manifestations in systemic lupus erythematosus: association with disease activity. Respirology 2015; 20 (03) 474-480
    PubMedSearch in Google Scholar
  • 64 Li M, Wang Q, Zhao J. , et al; CSTAR co-authors. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus 2014; 23 (10) 1085-1091
    CrossrefPubMedSearch in Google Scholar
  • 65 Prabu A, Patel K, Yee C-S. , et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 2009; 48 (12) 1506-1511
    CrossrefPubMedSearch in Google Scholar
  • 66 Johnson SR, Granton JT. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev 2011; 20 (122) 277-286
    CrossrefPubMedSearch in Google Scholar
  • 67 Yurkovich M, Vostretsova K, Chen W, Aviña-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014; 66 (04) 608-616
    PubMedSearch in Google Scholar
  • 68 Min HK, Lee JH, Jung SM. , et al. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. Korean J Intern Med (Korean Assoc Intern Med) 2015; 30 (02) 232-241
    CrossrefPubMedSearch in Google Scholar
  • 69 Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978; 57 (06) 545-560
    PubMedSearch in Google Scholar
  • 70 Benham H, Garske L, Vecchio P, Eckert BW. Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus. J Clin Rheumatol 2010; 16 (02) 68-70
    CrossrefPubMedSearch in Google Scholar
  • 71 Mayes MD, Lacey Jr JV, Beebe-Dimmer J. , et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48 (08) 2246-2255
    CrossrefPubMedSearch in Google Scholar
  • 72 Launay D, Remy-Jardin M, Michon-Pasturel U. , et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 2006; 33 (09) 1789-1801
    PubMedSearch in Google Scholar
  • 73 Fischer A, Swigris JJ, Groshong SD. , et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 2008; 134 (03) 601-605
    CrossrefPubMedSearch in Google Scholar
  • 74 Desai SR, Veeraraghavan S, Hansell DM. , et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232 (02) 560-567
    CrossrefPubMedSearch in Google Scholar
  • 75 Goldin JG, Kim GHJ, Tseng C-H. , et al. Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the Scleroderma Lung Study II. Ann Am Thorac Soc 2018; 15 (11) 1286-1295
    CrossrefPubMedSearch in Google Scholar
  • 76 Silva CIS, Müller NL, Lynch DA. , et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246 (01) 288-297
    CrossrefPubMedSearch in Google Scholar
  • 77 Akira M, Inoue Y, Kitaichi M, Yamamoto S, Arai T, Toyokawa K. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251 (01) 271-279
    CrossrefPubMedSearch in Google Scholar
  • 78 Chan TY, Hansell DM, Rubens MB, du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax 1997; 52 (03) 265-270
    CrossrefPubMedSearch in Google Scholar
  • 79 Zhan X, Koelsch T, Montner SM. , et al. Differentiating usual interstitial pneumonia from nonspecific interstitial pneumonia using high-resolution computed tomography: the “Straight-edge Sign”. J Thorac Imaging 2018; 33 (04) 266-270
    CrossrefPubMedSearch in Google Scholar
  • 80 Walkoff L, White DB, Chung JH, Asante D, Cox CW. The four corners sign: a specific imaging feature in differentiating systemic sclerosis-related interstitial lung disease from idiopathic pulmonary fibrosis. J Thorac Imaging 2018; 33 (03) 197-203
    CrossrefPubMedSearch in Google Scholar
  • 81 de Souza RBC, Borges CTL, Capelozzi VL. , et al. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis. Respiration 2009; 77 (04) 389-397
    CrossrefPubMedSearch in Google Scholar
  • 82 Fischer A, Misumi S, Curran-Everett D. , et al. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease. Chest 2007; 131 (04) 988-992
    CrossrefPubMedSearch in Google Scholar
  • 83 Bakker ME, Ninaber MK, Stolk J. , et al. Lung density and pulmonary artery diameter are predictors of pulmonary hypertension in systemic sclerosis. J Thorac Imaging 2017; 32 (06) 391-397
    CrossrefPubMedSearch in Google Scholar
  • 84 Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest 2006; 130 (04) 976-981
    CrossrefPubMedSearch in Google Scholar
  • 85 Stern EJ, Swensen SJ, Hartman TE, Frank MS. CT mosaic pattern of lung attenuation: distinguishing different causes. AJR Am J Roentgenol 1995; 165 (04) 813-816
    CrossrefPubMedSearch in Google Scholar
  • 86 Rajaram S, Swift AJ, Condliffe R. , et al. CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry. Thorax 2015; 70 (04) 382-387
    CrossrefPubMedSearch in Google Scholar
  • 87 Tyndall AJ, Bannert B, Vonk M. , et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69 (10) 1809-1815
    CrossrefPubMedSearch in Google Scholar
  • 88 Suliman YA, Dobrota R, Huscher D. , et al. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 2015; 67 (12) 3256-3261
    PubMedSearch in Google Scholar
  • 89 Tashkin DP, Roth MD, Clements PJ. , et al; Sclerodema Lung Study II Investigators. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 2016; 4 (09) 708-719
    CrossrefPubMedSearch in Google Scholar
  • 90 Kwon HM, Kang EH, Park JK. , et al. A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford) 2015; 54 (10) 1792-1796
    CrossrefPubMedSearch in Google Scholar
  • 91 Hax V, Bredemeier M, Didonet Moro AL. , et al. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis. Semin Arthritis Rheum 2017; 47 (02) 228-234
    CrossrefPubMedSearch in Google Scholar
  • 92 Goh NS, Desai SR, Veeraraghavan S. , et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177 (11) 1248-1254
    CrossrefPubMedSearch in Google Scholar
  • 93 Champtiaux N, Cottin V, Chassagnon G. , et al. Combined pulmonary fibrosis and emphysema in systemic sclerosis: a syndrome associated with heavy morbidity and mortality. Semin Arthritis Rheum 2018; pii: S0049-0172(17)30511-5
    PubMedSearch in Google Scholar
  • 94 Okamoto M, Fujimoto K, Sadohara J. , et al. A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease. Respir Investig 2016; 54 (06) 445-453
    CrossrefPubMedSearch in Google Scholar
  • 95 Enomoto Y, Nakamura Y, Colby TV. , et al. Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease. PLoS One 2017; 12 (06) e0180283
    CrossrefPubMedSearch in Google Scholar
  • 96 Antoniou KM, Margaritopoulos GA, Goh NS. , et al. Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension. Arthritis Rheumatol 2016; 68 (04) 1004-1012
    PubMedSearch in Google Scholar
  • 97 Gleason JB, Patel KB, Hernandez F. , et al. Pulmonary artery dimensions as a prognosticator of transplant-free survival in scleroderma interstitial lung disease. Hai 2017; 195 (04) 403-409
    PubMedSearch in Google Scholar
  • 98 Qin B, Wang J, Yang Z. , et al. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74 (11) 1983-1989
    PubMedSearch in Google Scholar
  • 99 Kampolis CF, Fragkioudaki S, Mavragani CP, Zormpala A, Samakovli A, Moutsopoulos HM. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome. Clin Exp Rheumatol 2018; 36 (3, suppl 112): 94-101
    PubMedSearch in Google Scholar
  • 100 Soto-Cardenas M-J, Perez-De-Lis M, Bove A. , et al. Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance. Clin Exp Rheumatol 2010; 28 (05) 647-653
    PubMedSearch in Google Scholar
  • 101 Nakanishi M, Fukuoka J, Tanaka T. , et al. Small airway disease associated with Sjögren's syndrome: clinico-pathological correlations. Respir Med 2011; 105 (12) 1931-1938
    CrossrefPubMedSearch in Google Scholar
  • 102 Borie R, Schneider S, Debray M-P. , et al. Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. Respir Med 2011; 105 (01) 130-136
    CrossrefPubMedSearch in Google Scholar
  • 103 Gao H, Zhang X-W, He J. , et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: a case-control study. Medicine (Baltimore) 2018; 97 (24) e11003
    PubMedSearch in Google Scholar
  • 104 Dong X, Zhou J, Guo X. , et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol 2018; 37 (11) 2981-2988
    CrossrefPubMedSearch in Google Scholar
  • 105 Johkoh T, Müller NL, Pickford HA. , et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212 (02) 567-572
    CrossrefPubMedSearch in Google Scholar
  • 106 Honda O, Johkoh T, Ichikado K. , et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol 1999; 173 (01) 71-74
    CrossrefPubMedSearch in Google Scholar
  • 107 Kokosi MA, Nicholson AG, Hansell DM, Wells AU. Rare idiopathic interstitial pneumonias: LIP and PPFE and rare histologic patterns of interstitial pneumonias: AFOP and BPIP. Respirology 2016; 21 (04) 600-614
    CrossrefPubMedSearch in Google Scholar
  • 108 Wislez M, Cadranel J, Antoine M. , et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999; 14 (02) 423-429
    PubMedSearch in Google Scholar
  • 109 Rajagopala S, Singh N, Gupta K, Gupta D. Pulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature. Respirology 2010; 15 (05) 860-866
    CrossrefPubMedSearch in Google Scholar
  • 110 Kobak S, Kalkan S, Kirilmaz B, Orman M, Ercan E. Pulmonary arterial hypertension in patients with primary Sjögren's syndrome. Autoimmune Dis 2014; 2014: 710401
    PubMedSearch in Google Scholar
  • 111 Sato T, Hatano M, Iwasaki Y. , et al. Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension. PLoS One 2018; 13 (05) e0197297
    CrossrefPubMedSearch in Google Scholar
  • 112 Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LTH. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65 (06) 796-803
    CrossrefPubMedSearch in Google Scholar
  • 113 Richards TJ, Eggebeen A, Gibson K. , et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 2009; 60 (07) 2183-2192
    CrossrefPubMedSearch in Google Scholar
  • 114 Oikonomou A, Hansell DM. Organizing pneumonia: the many morphological faces. Eur Radiol 2002; 12 (06) 1486-1496
    CrossrefPubMedSearch in Google Scholar
  • 115 Hozumi H, Fujisawa T, Nakashima R. , et al. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease. Respir Med 2016; 121: 91-99
    CrossrefPubMedSearch in Google Scholar
  • 116 Alqatari S, Riddell P, Harney S, Henry M, Murphy G. MDA-5 associated rapidly progressive interstitial lung disease with recurrent pneumothoraces: a case report. BMC Pulm Med 2018; 18 (01) 59
    CrossrefPubMedSearch in Google Scholar
  • 117 Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard J-F. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011; 63 (11) 3439-3447
    CrossrefPubMedSearch in Google Scholar
  • 118 Kang EH, Lee EB, Shin KC. , et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 2005; 44 (10) 1282-1286
    CrossrefPubMedSearch in Google Scholar
  • 119 Zamora AC, Hoskote SS, Abascal-Bolado B. , et al. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respir Med 2016; 118: 39-45
    CrossrefPubMedSearch in Google Scholar
  • 120 Tanizawa K, Handa T, Nakashima R. , et al. The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med 2013; 107 (05) 745-752
    CrossrefPubMedSearch in Google Scholar
  • 121 Gunnarsson R, Molberg O, Gilboe I-M, Gran JT. ; PAHNOR1 Study Group. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis 2011; 70 (06) 1047-1051
    CrossrefPubMedSearch in Google Scholar
  • 122 Gunnarsson R, Aaløkken TM, Molberg Ø. , et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis 2012; 71 (12) 1966-1972
    CrossrefPubMedSearch in Google Scholar
  • 123 Sullivan WD, Hurst DJ, Harmon CE. , et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984; 63 (02) 92-107
    PubMedSearch in Google Scholar
  • 124 Gunnarsson R, Andreassen AK, Molberg Ø. , et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology (Oxford) 2013; 52 (07) 1208-1213
    CrossrefPubMedSearch in Google Scholar
  • 125 Yamanaka Y, Baba T, Hagiwara E. , et al. Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis. Eur J Radiol 2018; 107: 26-32
    CrossrefPubMedSearch in Google Scholar
  • 126 Prakash UB, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 1985; 60 (12) 813-821
    CrossrefPubMedSearch in Google Scholar
  • 127 Kawano-Dourado L, Baldi BG, Kay FU. , et al. Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years. Clin Exp Rheumatol 2015; 33 (02) 234-240
    PubMedSearch in Google Scholar
  • 128 Collard HR, Ryerson CJ, Corte TJ. , et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med 2016; 194 (03) 265-275
    CrossrefPubMedSearch in Google Scholar
  • 129 Tachikawa R, Tomii K, Ueda H. , et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 2012; 83 (01) 20-27
    CrossrefPubMedSearch in Google Scholar
  • 130 Suda T, Kaida Y, Nakamura Y. , et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009; 103 (06) 846-853
    CrossrefPubMedSearch in Google Scholar
  • 131 Rice AJ, Wells AU, Bouros D. , et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am J Clin Pathol 2003; 119 (05) 709-714
    CrossrefPubMedSearch in Google Scholar
  • 132 Bhamra K, Stevens R. Pulmonary sarcoidosis following etanercept treatment. Case Rep Rheumatol 2012; 2012: 724013
    PubMedSearch in Google Scholar
  • 133 Kwon HJ, Coté TR, Cuffe MS, Kramer JM, Braun MM. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 2003; 138 (10) 807-811
    PubMedSearch in Google Scholar
  • 134 Rozin A, Yigla M, Guralnik L. , et al. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 2006; 25 (03) 384-388
    CrossrefPubMedSearch in Google Scholar
  • 135 Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009; 68 (07) 1100-1104
    CrossrefPubMedSearch in Google Scholar
  • 136 Mori S, Koga Y, Sugimoto M. Organizing pneumonia in rheumatoid arthritis patients: a case-based review. Clin Med Insights Circ Respir Pulm Med 2015; 9 (Suppl. 01) 69-80
    PubMedSearch in Google Scholar
  • 137 Padley SP, Adler B, Hansell DM, Müller NL. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992; 46 (04) 232-236
    CrossrefPubMedSearch in Google Scholar